ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY >
Evaluation of Liver Fibrosis on Grayscale Ultrasound in a Pediatric Population Using a Cloud-based Transfer Learning Artificial Intelligence Platform
1 Amr Mohammed and Aylin Tahmasebi contributed equally to this study.
Received date: 2024-09-15
Accepted date: 2024-10-24
Online published: 2024-11-12
Objectives: The incidence of chronic liver diseases in children is increasing worldwide due to congenital, metabolic, autoimmune and viral diseases. Currently, liver biopsy for fibrosis assessment is considered the gold standard. However, this procedure is invasive, may result in unavoidable complications and is prone to sampling errors. These limitations have led to an increasing demand for noninvasive methods for fibrosis screening. Artificial intelligence integration in ultrasound diagnosis of liver fibrosis has gained interest in clinical research. In the current study we used a cloud-based artificial intelligence platform utilizing transfer learning to evaluate the accuracy of B-mode ultrasound based AI model compared to pediatric radiologists in detection of liver fibrosis in a pediatric population.
Methods: For this IRB approved study, charts of 190 pediatric patients who were referred for liver biopsy and ultrasound were reviewed. On average 14 images of different liver areas were selected and a single image per decision was used for both radiologist and AI reads. A supervised machine learning model for image classification was developed using Google Vision AutoML (Google Inc., Mountain View, CA, USA). Data was divided for model development (80% of cases (154 cases) = 2324 images) and a model validation cohort for external testing (20% (36 cases) = 360 images). As a comparator, three blinded radiologists read the ultrasound images of the validation cohort and provided a binary diagnosis of fibrosis versus non fibrotic liver appearance. Tissue sampling was used as the reference standard for all cases.
Results: There were 99 and 91 patients in the biopsy proven fibrosis and non-fibrosis group, respectively. The model’s internal evaluation resulted in precision of 78.2%, recall of 78.5% and average precision of 87.7%. In the external validation cohort, three radiologists (Mean ± Standard Deviation) and Google AutoML (confidence interval (CI)) achieved a sensitivity of 42.04% ± 0.04 and 70.56% (63.32% to 77.10% CI), specificity of 50.18% ± 0.04 and 45.00% (37.59% to 52.58% CI), positive predictive value of 45.76% ± 0.01 and 56.19% (52.17% to 60.14% CI), negative predictive value of 46.39% ± 0.01 and 60.45% (53.65% to 66.86% CI) and accuracy of 46.11% ± 0.01 and 57.78% (52.49% to 62.94% CI). When evaluating agreement across multiple images from the same patient, intra-reader agreement was 77.2% for AutoML and 90.8%-92.5% for the 3 radiologists. The models' F1 scores for the development and validation cohort were 0.78 and 0.62, respectively.
Conclusions: Liver fibrosis assessment in children is challenging without biopsy. An ultrasound-based AI model showed high sensitivity compared to radiologists, albeit still without suitable diagnostic performance for clinical use.
Amr Mohammed, MD , Aylin Tahmasebi, MD , Sooji Kim, BS , Mostafa Alnoury, MD , Corinne E. Wessner, MS, MBA, RDMS, RVT , Tania Siu Xiao, MD , Sharon W. Gould, MD , Lauren A. May, MD , Heidi Kecskemethy, MS Ed, RDN, CBDT , David T. Saul, MD , John R. Eisenbrey, PhD . Evaluation of Liver Fibrosis on Grayscale Ultrasound in a Pediatric Population Using a Cloud-based Transfer Learning Artificial Intelligence Platform[J]. ADVANCED ULTRASOUND IN DIAGNOSIS AND THERAPY, 2024 , 8(4) : 242 -249 . DOI: 10.37015/AUDT.2024.240048
[1] | Ozdogan E, Arikan C. Liver fibrosis in children: a comprehensive review of mechanisms, diagnosis, and therapy. Clin Exp Pediatr 2022; 66:110-124. |
[2] | Pediatric Liver Disease: Biliary Atresia & NAFLD [Internet]. 2022 [cited 2024 Jul 23]. Available from: https://liverfoundation.org/about-your-liver/facts-about-liver-disease/pediatric-liver-disease/ |
[3] | Lakshminarayanan B, Davenport M. Biliary atresia: A comprehensive review. J Autoimmun 2016; 73:1-9. |
[4] | M?rginean CO, Meli? LE, Ghiga DV, S?s?ran MO. The assessment of liver fibrosis in children with obesity on two methods: transient and two dimensional shear wave elastography. Sci Rep 2019; 9:19800. |
[5] | Hunter AK, Lin HC. Review of clinical guidelines in the diagnosis of pediatric nonalcoholic fatty liver disease. Clin Liver Dis 2021; 18:40-44. |
[6] | Sumida Y, Nakajima A, Itoh Y. Limitations of liver biopsy and non-invasive diagnostic tests for the diagnosis of nonalcoholic fatty liver disease/nonalcoholic steatohepatitis. World J Gastroenterol 2014; 20:475-485. |
[7] | Ovchinsky N, Moreira RK, Lefkowitch JH, Lavine JE. The liver biopsy in modern clinical practice: A pediatric point-of-view. Adv Anat Pathol 2012; 19:250-262. |
[8] | Ajmera V, Loomba R. Imaging biomarkers of NAFLD, NASH and fibrosis. Mol Metab 2021; 50:101167. |
[9] | Nogami A, Yoneda M, Iwaki M, Kobayashi T, Kessoku T, Honda Y, et al. Diagnostic comparison of vibration-controlled transient elastography and MRI techniques in overweight and obese patients with NAFLD. Sci Rep 2022; 12:21925. |
[10] | Bonekamp S, Kamel I, Solga S, Clark J. Can imaging modalities diagnose and stage hepatic fibrosis and cirrhosis accurately? J Hepatol 2009; 50:17-35. |
[11] | Di Serafino M, Severino R, Gioioso M, Rossi E, Vezzali N, Pelliccia P, et al. Paediatric liver ultrasound: a pictorial essay. J Ultrasound 2020; 23:87-103. |
[12] | Choong CC, Venkatesh SK, Siew EPY. Accuracy of routine clinical ultrasound for staging of liver fibrosis. J Clin Imaging Sci 2012; 2:58. |
[13] | Mueller-Abt PR, Frawley KJ, Greer RM, Lewindon PJ. Comparison of ultrasound and biopsy findings in children with cystic fibrosis related liver disease. J Cyst Fibros 2008; 7:215-221. |
[14] | He J, Baxter SL, Xu J, Xu J, Zhou X, Zhang K. The practical implementation of artificial intelligence technologies in medicine. Nat Med 2019; 25:30-36. |
[15] | Murillo Pineda MI, Siu Xiao T, Sanabria Herrera EJ, Ayala Aguilar A, Arriaga Escamilla D, Aleman Reyes AM, et al. The prediction and treatment of bleeding esophageal varices in the artificial intelligence era: A review. Cureus 2024; 16:e55786. |
[16] | Rezazade Mehrizi MH, van Ooijen P, Homan M. Applications of artificial intelligence (AI) in diagnostic radiology: a technography study. Eur Radiol 2021; 31:1805-1811. |
[17] | Ruan D, Shi Y, Jin L, Yang Q, Yu W, Ren H, et al. An ultrasound image‐based deep multi‐scale texture network for liver fibrosis grading in patients with chronic HBV infection. Liver Int 2021; 41:2440-2454. |
[18] | Xue LY, Jiang ZY, Fu TT, Wang QM, Zhu YL, Dai M, et al. Transfer learning radiomics based on multimodal ultrasound imaging for staging liver fibrosis. Eur Radiol 2020; 30:2973-2983. |
[19] | Kvostikov AV, Krylov AS, Kamalov UR. Ultrasound image texture analysis for liver fibrosis stage diagnostics. Program Comput Softw 2015; 41:273-278. |
[20] | Sriharsha Gummadi MD. Automated machine learning in the sonographic diagnosis of non-alcoholic fatty liver disease. Adv ULTRASOUND Diagn Ther 2020; 4:176-182. |
[21] | Wang S, Xu J, Tahmasebi A, Daniels K, Liu JB, Curry J, et al. Incorporation of a machine learning algorithm with object detection within the thyroid imaging reporting and data system improves the diagnosis of genetic risk. Front Oncol 2020; 10:591846. |
[22] | Tahmasebi A, Qu E, Sevrukov A, Liu JB, Wang S, Lyshchik A, et al. Assessment of axillary lymph nodes for metastasis on ultrasound using artificial intelligence. Ultrason Imaging 2021; 43:329-336. |
[23] | Tahmasebi A, Wang S, Wessner CE, Vu T, Liu JB, Forsberg F, et al. Ultrasound-based machine learning aapproach for detection of nonalcoholic fatty liver disease. J Ultrasound Med 2023; 42:1747-1756. |
[24] | Machado P, Tahmasebi A, Fallon S, Liu JB, Dogan BE, Needleman L, et al. Characterizing sentinel lymph node status in breast cancer patients using a deep-learning model compared with radiologists’ analysis of grayscale ultrasound and lymphosonography. Ultrasound Q 2024; 40:e00683. |
[25] | Daniels K, Gummadi S, Zhu Z, Wang S, Patel J, Swendseid B, et al. Machine learning by ultrasonography for genetic risk stratification of thyroid nodules. JAMA Otolaryngol-- Head Neck Surg 2020; 146:36-41. |
[26] | Faes L, Liu X, Wagner SK, Fu DJ, Balaskas K, Sim DA, et al. A clinician’s guide to artificial intelligence: How to critically appraise machine learning studies. Transl Vis Sci Technol 2020; 9:7. |
[27] | Liu Y, Chen PHC, Krause J, Peng L. How to read articles that use machine learning: Users’ guides to the medical literature. JAMA 2019; 322:1806-1816. |
[28] | Duan YY, Qin J, Qiu WQ, Li SY, Li C, Liu AS, et al. Performance of a generative adversarial network using ultrasound images to stage liver fibrosis and predict cirrhosis based on a deep-learning radiomics nomogram. Clin Radiol 2022; 77:e723-731. |
[29] | Liu Z, Wen H, Zhu Z, Li Q, Liu L, Li T, et al. Diagnosis of significant liver fibrosis in patients with chronic hepatitis B using a deep learning-based data integration network. Hepatol Int 2022; 16:526-536. |
[30] | Feng X, Chen X, Dong C, Liu Y, Liu Z, Ding R, et al. Multi-scale information with attention integration for classification of liver fibrosis in B-mode US image. Comput Methods Programs Biomed 2022; 215:106598. |
[31] | Lee JH, Joo I, Kang TW, Paik YH, Sinn DH, Ha SY, et al. Deep learning with ultrasonography: automated classification of liver fibrosis using a deep convolutional neural network. Eur Radiol 2020; 30:1264-1273. |
[32] | Al-Hasani M, Sultan LR, Sagreiya H, Cary TW, Karmacharya MB, Sehgal CM. Ultrasound radiomics for the detection of early-stage liver fibrosis. Diagnostics 2022; 12:2737. |
[33] | Cheng HY, Wang HY, Chang WH, Lin SC, Chu CH, Wang TE, et al. Nonalcoholic fatty liver disease: Prevalence, influence on age and sex, and relationship with metabolic syndrome and insulin resistance. Int J Gerontol 2013; 7:194-198. |
[34] | Heyens LJM, Busschots D, Koek GH, Robaeys G, Francque S. Liver fibrosis in non-alcoholic fatty liver disease: From liver biopsy to non-invasive biomarkers in diagnosis and treatment. Front Med 2021; 8:615978. |
[35] | Krishnan G, Singh S, Pathania M, Gosavi S, Abhishek S, Parchani A, et al. Artificial intelligence in clinical medicine: catalyzing a sustainable global healthcare paradigm. Front Artif Intell 2023; 6:1227091. |
[36] | Das A, Connell M, Khetarpal S. Digital image analysis of ultrasound images using machine learning to diagnose pediatric nonalcoholic fatty liver disease. Clin Imaging 2021; 77:62-68. |
[37] | Zhou W, Yang Y, Yu C, Liu J, Duan X, Weng Z, et al. Ensembled deep learning model outperforms human experts in diagnosing biliary atresia from sonographic gallbladder images. Nat Commun 2021; 12:1259. |
[38] | Hsu FR, Dai ST, Chou CM, Huang SY. The application of artificial intelligence to support biliary atresia screening by ultrasound images: A study based on deep learning models. PLOS ONE 2022; 17:e0276278. |
/
〈 | 〉 |